Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-20-000010
Filing Date
2020-05-12
Accepted
2020-05-12 16:32:30
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20200331.htm   iXBRL 10-Q 1816007
2 RESTATED CERTIFICATE OF INCORPORATION exhibit31postipocertif.htm EX-3.1 57427
3 RESTATED BYLAWS exhibit32postipobylaws.htm EX-3.2 290817
4 RULE 13A-14(A) CERTIFICATION exhibit311ceo.htm EX-31.1 11885
5 RULE 13A-14(A) CERTIFICATION exhibit312cfo.htm EX-31.2 11857
6 SECTION 1350 CERTIFICATIONS exhibit321ceocfo.htm EX-32.1 8867
  Complete submission text file 0001787306-20-000010.txt   7323395

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20200331.xsd EX-101.SCH 39871
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20200331_cal.xml EX-101.CAL 61071
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20200331_def.xml EX-101.DEF 224713
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20200331_lab.xml EX-101.LAB 536807
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20200331_pre.xml EX-101.PRE 364860
25 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20200331_htm.xml XML 1137996
Mailing Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 20869538
SIC: 2834 Pharmaceutical Preparations